Salmaan Al‐Qureshi

525 total citations
16 papers, 316 citations indexed

About

Salmaan Al‐Qureshi is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Nephrology. According to data from OpenAlex, Salmaan Al‐Qureshi has authored 16 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Ophthalmology, 6 papers in Radiology, Nuclear Medicine and Imaging and 1 paper in Nephrology. Recurrent topics in Salmaan Al‐Qureshi's work include Retinal Diseases and Treatments (9 papers), Retinal and Optic Conditions (5 papers) and Retinal Imaging and Analysis (5 papers). Salmaan Al‐Qureshi is often cited by papers focused on Retinal Diseases and Treatments (9 papers), Retinal and Optic Conditions (5 papers) and Retinal Imaging and Analysis (5 papers). Salmaan Al‐Qureshi collaborates with scholars based in Australia, Japan and Indonesia. Salmaan Al‐Qureshi's co-authors include Xavier Fagan, Lyndell L. Lim, Julie Morrison, Lauren Hodgson, Robyn H. Guymer, Meri Vukicevic, Sanjeewa Wickremasinghe, Sukhpal S. Sandhu, Marios Constantinou and Sophie Rogers and has published in prestigious journals such as Investigative Ophthalmology & Visual Science, British Journal of Ophthalmology and Clinical and Experimental Ophthalmology.

In The Last Decade

Salmaan Al‐Qureshi

16 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Salmaan Al‐Qureshi Australia	9	225	137	39	34	24	16	316
Sanjiv Banerjee United Kingdom	7	188 0.8×	171 1.2×	4 0.1×	38 1.1×	10 0.4×	12	260
J. Katsimpris Greece	12	337 1.5×	201 1.5×	18 0.5×	38 1.1×	2 0.1×	37	427
Kenneth Choong Sian Fong Malaysia	9	105 0.5×	36 0.3×	4 0.1×	21 0.6×	7 0.3×	13	187
Wan T. Tay Singapore	3	192 0.9×	249 1.8×	5 0.1×	11 0.3×	4 0.2×	3	294
Aura Falck Finland	14	318 1.4×	245 1.8×	2 0.1×	51 1.5×	7 0.3×	36	435
P. H. Bennett United States	8	76 0.3×	60 0.4×	6 0.2×	35 1.0×	4 0.2×	10	278
Su Chi Lim Singapore	3	301 1.3×	275 2.0×	3 0.1×	17 0.5×	4 0.2×	5	367
Livio Vitiello Italy	10	114 0.5×	73 0.5×	2 0.1×	15 0.4×	6 0.3×	33	201
Yasin Şakir Göker Türkiye	12	321 1.4×	215 1.6×	2 0.1×	85 2.5×	4 0.2×	35	457
Yuanjun Qin China	6	202 0.9×	38 0.3×	5 0.1×	32 0.9×	8 0.3×	13	299

Countries citing papers authored by Salmaan Al‐Qureshi

Since Specialization

Citations

This map shows the geographic impact of Salmaan Al‐Qureshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salmaan Al‐Qureshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salmaan Al‐Qureshi more than expected).

Fields of papers citing papers by Salmaan Al‐Qureshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salmaan Al‐Qureshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salmaan Al‐Qureshi. The network helps show where Salmaan Al‐Qureshi may publish in the future.

Co-authorship network of co-authors of Salmaan Al‐Qureshi

This figure shows the co-authorship network connecting the top 25 collaborators of Salmaan Al‐Qureshi. A scholar is included among the top collaborators of Salmaan Al‐Qureshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salmaan Al‐Qureshi. Salmaan Al‐Qureshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Shortt, Jake, et al.. (2024). Intravitreal anti-vascular endothelial growth factor therapy in the treatment of vision loss associated with hematologic malignancy. American Journal of Ophthalmology Case Reports. 36. 102095–102095. 2 indexed citations

Campbell, Thomas G. & Salmaan Al‐Qureshi. (2022). Ophthalmologists and climate change. Clinical and Experimental Ophthalmology. 50(3). 274–279. 3 indexed citations

Casson, Robert J. & Salmaan Al‐Qureshi. (2020). The scientific journal in the post‐truth era. Clinical and Experimental Ophthalmology. 48(2). 153–154. 1 indexed citations

Sasongko, Muhammad Bayu, Sophie Rogers, Marios Constantinou, et al.. (2020). Diabetic retinopathy progression 6 months post‐cataract surgery with intravitreous bevacizumab vs triamcinolone: A secondary analysis of the DiMECAT trial. Clinical and Experimental Ophthalmology. 48(6). 793–801. 3 indexed citations

Constantinou, Marios, Sophie Rogers, Sukhpal S. Sandhu, et al.. (2019). Prospective randomised clinical trial of intravitreal bevacizumab versus triamcinolone in eyes with diabetic macular oedema undergoing cataract surgery: 6-month results. British Journal of Ophthalmology. 103(12). bjophthalmol–2018. 12 indexed citations

Lim, Lyndell L., Marios Constantinou, Sophie Rogers, et al.. (2018). The DiMECat Trial: A Prospective, Randomised Clinical Trial Of Intravitreous Bevacizumab vs. Triamcinolone In Patients With Diabetic Macular Oedema At The Time Of Cataract Surgery – 6 Month Results. Investigative Ophthalmology & Visual Science. 59(9). 1958–1958. 2 indexed citations

Wijngaarden, Peter van, et al.. (2018). Early worsening of diabetic retinopathy due to intensive glycaemic control. Clinical and Experimental Ophthalmology. 47(2). 265–273. 9 indexed citations

Ong, Daini, Sukhpal S. Sandhu, David L. Ware, et al.. (2017). Paracentral acute middle maculopathy as a finding in patients with severe vision loss following phacoemulsification cataract surgery. Clinical and Experimental Ophthalmology. 45(6). 598–605. 23 indexed citations

Morrison, Julie, Lauren Hodgson, Lyndell L. Lim, & Salmaan Al‐Qureshi. (2016). Diabetic retinopathy in pregnancy: a review. Clinical and Experimental Ophthalmology. 44(4). 321–334. 73 indexed citations

10.

Lim, Lyndell L., Julie Morrison, Marios Constantinou, et al.. (2016). Diabetic Macular Edema at the time of Cataract Surgery trial: a prospective, randomized clinical trial of intravitreous bevacizumab versus triamcinolone in patients with diabetic macular oedema at the time of cataract surgery – preliminary 6 month results. Clinical and Experimental Ophthalmology. 44(4). 233–242. 27 indexed citations

11.

Razavi, Hessom, Salmaan Al‐Qureshi, & Alex Harper. (2016). Exudative cotton wool spots: an under‐recognized variant of a common lesion. Clinical and Experimental Ophthalmology. 44(7). 631–634. 1 indexed citations

12.

Fagan, Xavier & Salmaan Al‐Qureshi. (2013). Intravitreal injections: a review of the evidence for best practice: response. Clinical and Experimental Ophthalmology. 42(1). 98–100. 1 indexed citations

13.

Fagan, Xavier, et al.. (2013). Review of the role of refined dietary sugars (fructose and glucose) in the genesis of retinal disease. Clinical and Experimental Ophthalmology. 42(6). 564–573. 16 indexed citations

14.

Al‐Qureshi, Salmaan, et al.. (2012). Therapeutic targeting of the complement system in age‐related macular degeneration: a review. Clinical and Experimental Ophthalmology. 40(1). 18–26. 50 indexed citations

15.

Fagan, Xavier & Salmaan Al‐Qureshi. (2012). Intravitreal injections: a review of the evidence for best practice. Clinical and Experimental Ophthalmology. 41(5). 500–507. 45 indexed citations

16.

Vukicevic, Meri, et al.. (2011). Prevalence of optical coherence tomography‐diagnosed postoperative cystoid macular oedema in patients following uncomplicated phaco‐emulsification cataract surgery. Clinical and Experimental Ophthalmology. 40(3). 282–287. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact